Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGastelurrutia, Paloma
dc.contributor.authorPrat-Vidal, Cristina
dc.contributor.authorVives Armengol, Joaquim
dc.contributor.authorColl, Ruth
dc.contributor.authorBayes-Genis, Antoni
dc.contributor.authorGálvez-Montón, Carolina
dc.date.accessioned2021-07-07T12:37:38Z
dc.date.available2021-07-07T12:37:38Z
dc.date.issued2021-02-04
dc.identifier.citationGastelurrutia P, Prat-Vidal C, Vives J, Coll R, Bayes-Genis A, Gálvez-Montón C. Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience. Front Cardiovasc Med. 2021 Feb 4;8:604434.
dc.identifier.issn2297-055X
dc.identifier.urihttps://hdl.handle.net/11351/6128
dc.descriptionMedicament de teràpia avançada; Medicament en investigació; Translacional (regulació)
dc.description.sponsorshipThis work was supported by the Spanish Cell Therapy Network (TerCel) [RD16/0011/0006 and RD16/0011/0028]; and CIBER Cardiovascular [CB16/11/00403] projects, as a part of the National R&D&I Plan, and was co-funded by the ISCIII-Sub-Directorate General for Research Assessment and Promotion and the European Regional Development Fund (ERDF); the Government of Catalonia: Agency for Management of University and Research Grants (AGAUR) [2017-SGR-483 and 2017-SGR-719], PERIS Program (Health Department) [SLT002/16/00234 and SLT002/16/00209] and CERCA Program; La Caixa Banking Foundation; grants from the Spanish Ministry of Science, Innovation and Universities (MICINN) [SAF2017-84324-C2-1-R]; Institute of Health Carlos III (ISCIII) [PI18/00256, PIC18/00014, ICI19/00039, and PI19/01788], and cofunded by European Union (ERDF/ESF) - A way to build Europe. This work has also been funded by the Sociedad Española de Cardiología and by the Call for Expression of Interest (EoI) for Collaborative Projects on Regenerative Medicine 2019 of Center for Regenerative Medicine of Barcelona (CMR[B]). The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Cardiovascular Medicine;8
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectMedicina - Investigació - Espanya
dc.subjectMedicina basada en l'evidència
dc.subjectMedicaments - Desenvolupament
dc.subject.meshTranslational Medical Research
dc.subject.meshTherapies, Investigational
dc.subject.meshSpain
dc.titleTransitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fcvm.2021.604434
dc.subject.decsinvestigación médica traslacional
dc.subject.decstratamientos en investigación
dc.subject.decsEspaña
dc.relation.publishversionhttps://www.frontiersin.org/articles/10.3389/fcvm.2021.604434/full
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Gastelurrutia P, Prat-Vidal C] Institut d'Investigació Biomèdica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain. Insuficiencia Cardíaca y Regeneración Cardíaca Research Program, Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Spain. Centro de Investigación Biomédica en Red Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain. [Vives J] Servei de Teràpia Cel·lular, Banc de Sang i Teixits, Barcelona, Spain. Grup d’Enginyeria tissular musculoesquelètica, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Coll R] Servei de Teràpia Cel·lular, Banc de Sang i Teixits, Barcelona, Spain. [Bayes-Genis A] Insuficiencia Cardíaca y Regeneración Cardíaca Research Program, Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Spain. Centro de Investigación Biomédica en Red Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain. Hospital Universitari Germans Trias i Pujol, Badalona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Gálvez-Montón C] Insuficiencia Cardíaca y Regeneración Cardíaca Research Program, Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP), Badalona, Spain. Centro de Investigación Biomédica en Red Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain
dc.identifier.pmid33614746
dc.identifier.wos000619000600001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0011%2F0028
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0011%2F0006
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F11%2F00403
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR483
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR719
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PERIS2016-2020/SLT002%2F16%2F00234
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PERIS2016-2020/SLT002%2F16%2F00209
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/SAF2017-84324-C2-1-R
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/PI18%2F00256
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/PIC18%2F00014
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2017-2020/ICI19%2F00039
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F01788
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple